I hope you guys get your approvals. If you
take an honest look at MYX’s graph it is
continuing it’s downtrend. Never under
estimate the damage that poor
management does to a company’s
reputation and to it’s share price. Seen
this before. Retails think they are geniuses
for stumbling across a hidden gem. Most
of the proposed success hinges on Myring and E4
approvals. Remove those approvals from the
equation and this is what is left in a very competitive
field. If Myring gets approved it becomes the third
generic. Big deal. Who cares? No guarantees it
will get through so put that to the side. E4 again big deal.
There’s a lot of hype around a new OCP. So much economic
damage done in the States with more to come in a global
pandemic. People in the States are on low wages or unemployed.
Tens of millions unemployed. Very unfortunate time to
be releasing a new whiz bang OCP at the beginning of
a potential depression. Myx has a knack of getting its
timing wrong on a lot of things and has clearly lost the
confidence of the market with poor decision making
and execution. There are many market opportunities
out there with emerging technologies. The market is
totally unforgiving for incompetence. I feel sorry for
longs caught up in SR’s mess with no way out. SP
bounce will come with approvals and hopefully longs
who are heavily under water can get out and break even.
Putting most of your hard earned into one stock can
backfire badly and provides a great lesson especially
for retails. Myx is a gamble so people should only gamble
what they can comfortably afford to lose. If you’re not
sleeping comfortably at night due to Myx investment
then rebalance. We all get it wrong sometimes
- Forums
- ASX - By Stock
- Is MYX a bargain
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

I hope you guys get your approvals. If youtake an honest look at...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
2 | 3150 | 5.040 |
1 | 600 | 5.030 |
3 | 3000 | 5.000 |
1 | 10000 | 4.980 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.180 | 2396 | 2 |
5.190 | 5000 | 1 |
5.200 | 157 | 1 |
5.210 | 5000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online